Metabolites › SMZYCXAYGPGYRS-NGTUZWGPSA-N

Isoastragaloside II

[(2S,3R,4S,5R)-3,5-dihydroxy-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]oxan-4-yl] acetate

SMZYCXAYGPGYRS-NGTUZWGPSA-N CHEBI:190284 0 Reactome links 1 studies
1 Observed studies
1 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
SMZYCXAYGPGYRS-NGTUZWGPSA-N
InChI Key
SMZYCXAYGPGYRS-NGTUZWGPSA-N
IUPAC name
[(2S,3R,4S,5R)-3,5-dihydroxy-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]oxan-4-yl] acetate
Preferred name
Isoastragaloside II
INN name
—
Synonym
—
ChEBI
CHEBI:190284

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles